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Low-carbohydrate diets affect energy balance and fuel homeostasis
differentially in lean and obese rats. Am J Physiol Regul Integr Comp
Physiol 291: R1622–R1629, 2006. First published August 10, 2006;
doi:10.1152/ajpregu.00128.2006.—In parallel with increased preva-
lence of overweight people in afﬂuent societies are individuals trying
to lose weight, often using low-carbohydrate diets. Nevertheless,
long-term metabolic consequences of those diets, usually high in
(saturated) fat, remain unclear. Therefore, we investigated long-term
effects of high-fat diets with different carbohydrate/protein ratios on
energy balance and fuel homeostasis in obese (fa/fa) Zucker and lean
Wistar rats. Animals were fed high-carbohydrate (HC), high-fat
(HsF), or low-carbohydrate, high-fat, high-protein (LC-HsF-HP) diets
for 60 days. Both lines fed the LC-HsF-HP diet displayed reduced
energy intake compared with those fed the HsF diet (Zucker, 23.7%)
or the HC diet (Wistar rats, 212.4%). This was not associated with
lower weight gain relative to HC fed rats, because of increased food
efﬁciencies in each line fed HsF and particularly LC-HsF-HP food.
Zucker rats were less glucose tolerant than Wistar rats. Lowest
glucose tolerances were found in HsF and particularly in LC-HsF-
HP-fed animals irrespective of line, but this paralleled reduced plasma
adiponectin levels, elevated plasma resistin levels, higher retroperito-
neal fat masses, and reduced insulin sensitivity (indexed by insulin-
induced hypoglycemia) only in Wistar rats. In Zucker rats, however,
improved insulin responses during glucose tolerance testing and
tendency toward increased insulin sensitivities were observed with
HsF or LC-HsF-HP feeding relative to HC feeding. Thus, despite
adverse consequences of LC-HsF diets on blood glucose homeostasis,
principal differences exist in the underlying hormonal regulatory
mechanisms, which could have beneﬁts for B-cell functioning and
insulin action in the obese state but not in the lean state.
fa/fa Zucker rats; glucose tolerance; insulin sensitivity
OBESITY HAS REACHED EPIDEMIC proportions in most afﬂuent
societies, and this is associated with a dramatic rise in meta-
bolic/endocrine (e.g., Type 2 diabetes) and cardiovascular
diseases (14). Ironically, these trends are paralleled by a large
number of individuals trying to lose weight (24) and by the
large sums of money spent on weight loss products and
services (6). Although guidelines for successful weight loss
include a reduction of caloric intake combined with increased
physical exercise (20, 37), considerable public interest has
been aimed at the use of low-carbohydrate diets to attain
successful weight loss (27). For example, the “Atkins diet” (at
least 45 million copies of books sold over 40 years) is currently
embraced by over 20 million people worldwide (2).
In accordance with public enthusiasm are several recently
published studies reporting, in obese people, an improvement
of sustained weight loss after 6 mo on a low-carbohydrate
(“ketogenic”) diet compared with the results obtained with a
more conventional low-fat, low-calorie diet (8, 17, 27, 38).
These differences in weight loss, however, disappeared after 12
mo, and associated metabolic correlates (e.g., insulin resistance
and glucose tolerance) only showed marginal improvements.
One potential problem associated with chronic ingestion of
a low-carbohydrate diet is that it usually contains lots of fat to
compensate for the reduction of calories due to lack of carbo-
hydrates. This way, low-carbohydrate diets can contain up to
60% of fat and, not infrequently, mostly in the form of
saturated fat (16). For years, scientists and health ofﬁcials have
warned against the adverse health consequences of saturated
fat, as it can lead to dislipidemia, insulin resistance, and
glucose intolerance. It may, therefore, be hypothesized that
these effects also occur with the consumption of a low-
carbohydrate (ketogenic) diet with a high fat content. Thus, to
assess the health consequences of increased dietary fat, irre-
spective of carbohydrate content, the present study was de-
signed to investigate the effects of chronic consumption of
high-fat diets with different carbohydrate/protein ratios on
energy balance and fuel homeostasis in normal Wistar and in
obese fa/fa Zucker rats. The latter animals were included in our
study as a rodent model of obesity and insulin resistance. The
fa/fa Zucker rat has a single mutation in the gene encoding the
leptin receptor (13), which renders this rat less sensitive to
leptin (1, 23). Although homologous mutations are extremely
rare in the human population (7), and thus probably not
underlying the current epidemic of obesity and metabolic
syndrome in afﬂuent societies, there is support for the notion
that leptin resistance is a correlate of human obesity, as well as
of the development and progression of the metabolic syndrome
(39). Therefore, studying the effects of chronic consumption of
high-fat diets with different carbohydrate/protein ratios in lep-
tin-resistant obese fa/fa Zucker rats may be highly relevant for
judgment of the potentially beneﬁcial or adverse health con-
sequences in leptin-resistant individuals.
MATERIALS AND METHODS
Animals and diets. Male Wistar rats (n 5 36) were obtained from
the breeding colony maintained by the Department of Animal Phys-
iology at the University of Groningen. Male Zucker fa/fa (HsdOla:
ZUCKER Leprfa, n 5 40) rats were purchased from Harlan Nederland
(Horst, The Netherlands) at the age of 6 wk. All rats were allowed 10
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 days to habituate to their housing conditions (i.e., individual housing
in rooms with controlled humidity and temperature, 12:12-h light-dark
cycle, with lights on from 0300 to 1500). Then, three cohorts, matched
for mean body weight within the fa/fa Zucker group (247 6 5 g) and
within the Wistar group (264 6 5g), were switched to one of the
different experimental diets. These pelleted isocaloric diets were 1) a
high-carbohydrate diet (HC, standard laboratory chow), 2) a high-
(saturated) fat diet (HsF) and 3) a low-carbohydrate, high-(saturated)
fat, high-protein (LC-HsF-HP) diet. The composition of the diets is
presented in Table 1. The HsF and LC-HsF-HP diets were prepared by
adding casein (Merck by Boom, Meppel, The Netherlands), corn oil
(Albert Heijn, Zaandam, The Netherlands), beef tallow (Ossewit, NV
Vandemoortele Roosendaal, Roosendaal, The Netherlands), cellulose
(Bufa, Uitgeest, The Netherlands), guar gum (Merck by Boom), and
vitamins and salt mixtures (prepared with components purchased from
Sigma Aldrich, Zwijndrecht, The Netherlands) to the standard labo-
ratory chow diet (RMH-B, Hope Farms, Woerden, The Netherlands)
up to the levels given in Table 1.
Food intake and body weight were assessed daily. All methods and
experiments were approved and checked by the Animal Care Com-
mittee of the University of Groningen.
Surgery. Between day 35 and day 40 of the experiment, under
N2O-isoﬂurane anesthesia, rats were implanted with two indwelling
silicon catheters, inserted in the right and left jugular vein to allow
blood sampling and infusions, respectively. Surgery was performed as
described previously (26). Both cannulas were externalized on top of
the skull and secured with dental cement. Animals were injected with
Finadyne (1 g/kg body wt, Schering-Plough, Maarssen, The Nether-
lands) for analgesia following surgery.
Intravenous glucose tolerance test. On one day between day 45 and
day 50, food was removed at lights on, and animals were subjected to
an intravenous glucose tolerance test (IVGTT), which was performed
during the last hours of the light phase. Speciﬁcally, the rats were
connected to sampling and infusion tubing, which extended out of the
rat cages for remote blood sampling and intravenous infusion, respec-
tively. After connection to the tubing, animals were left undisturbed
for 45 min before starting the experiment. Two baseline blood
samples (100 ml) were taken 10 and 5 min before the start of an
infusion of a 10% glucose solution (in sterile saline) at a rate of 0.1
ml/min for 20 min. Blood samples (100 ml) were taken 1, 3, 5, 7, 10,
15, 20, 23, 26, 30, 40, and 50 min after the start of the infusion for
glucose and insulin measurements. After each sample was collected,
an equivalent volume of sterile saline was given back to the rats to
avoid major disturbances in hemodynamics.
Insulin sensitivity test. Seven days after the IVGTT, animals were
food-deprived overnight and were subjected to an insulin sensitivity
test (IST) during the last hours before the dark phase. Again, rats were
connected to the blood sampling tubing 45 min before the ﬁrst blood
sample. After a baseline blood sample (100 ml) was collected, rats
were injected intraperitoneally with a solution of insulin (Velosulin,
Novo Nordisk Farma, Bagsvaerd, Denmark) at a dose of 5 U/kg and
0.5 U/kg for the fa/fa Zucker and the Wistar rats, respectively. Blood
(100 ml) was then sampled after 15, 30, 45, and 60 min for glucose
and insulin measurements.
Blood and tissue collection and analysis. On day 60, rats were
killed by decapitation under CO2 anesthesia. Trunk blood was col-
lected in ice-cooled tubes containing Trasylol and EDTA. Plasma
samples, obtained after centrifugation (10 min, 1,500 g, 4°C) were
stored at 280°C until analysis. Plasma glucose levels were assessed
by the ferricyanide method of Hoffman (11). Plasma levels of insulin,
leptin, resistin, and adiponectin were measured by commercial radio-
immunoassay kits (RI-13 K, GL-32 K, and MADP-60 HK, respec-
tively; Linco Research, St. Charles, MO). Plasma concentration of
free fatty acids, triglycerides, and ketones were assessed using a
commercial kit (Boeringher Mannheim, Mannheim, Germany). Car-
cass analysis was performed by assessing wet weights of liver,
retroperitoneal fat mass (both sides), gastrointestinal tract, kidneys
(both), and eviscerated carcasses.
Calculations and statistical analysis. Results are expressed as
means 6 SE. Areas under the curve (AUC) of blood glucose and
plasma insulin responses were calculated using the trapezoidal
method relative to baseline and over the full period of sampling
following the start of intravenous glucose infusion (i.e., IVGTT).
Food efﬁciencies (FE; mg body wt/kcal) were calculated as the ratio
between body weight (g) gained over the ﬁrst month of dietary
treatment and the total amount of food (kcal) ingested during that
period of time. All statistical analyses were done using SPSS 11.0
(Chicago, IL) and were performed within each rat line. A one-way
ANOVA was used to compare values obtained at the end of the
experimental period, as well as the daily body weight gain, daily
energy intake, and food efﬁciencies. Concerning the IVGTT and IST
experiments, the diet effect (HsF, LC-HsF-HP, and HC) was evalu-
ated using an ANOVA with repeated measures, with one within-
subject factor (time) and one between-group factor (diet 5 HsF,
LC-HsF-HP, or HC). Tukey’s test was used for post hoc analysis. The
level of signiﬁcance was set at P , 0.05 for all tests.
RESULTS
Body weight and energy intake and efﬁciency. Figure 1
presents the average daily energy intake (A), body weight gain
(B), and the FEs (C) calculated over the ﬁrst month of the
experiment, that is, before rats underwent surgeries. As ex-
pected, clear differences were observed between fa/fa Zucker
Table 1. Composition of the diets
Standard Chow diet, HC High-(Saturated) Fat Diet
High-(Saturated) Fat,
High-Protein Diet
g/kg %energy g/kg %energy g/kg %energy
Protein 228 23 200 20.4 340 34.7
Crude (lab chow) 228 69 18
Added casein 131 322
Fat (saturated fat) 55 (0.7) 14 260 (94.3) 60.2 260 (99.6) 60.2
Lab chow fat 55 17 4
Added corn oil 74 77
Added beef tallow 169 179
Carbohydrates 625 63 190 19.4 50 5.1
Lab chow
Polysaccharides 600 182 48
Simple sugars 25 8 2
Metabolizable energy 3.8 kcal/g 3.9 kcal/g 3.9 kcal/g
HC, high carbohydrate.
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 and Wistar rats irrespective of diet, with energy intake, body
weight gain, and FEs all being elevated in the fa/fa Zucker rats
relative to the Wistar rats. Within each rat line, diet composi-
tion caused differential effects on above-mentioned parame-
ters. For example, although diet composition failed to affect
body weight gain of the Wistar rats, body weight gain in the
fa/fa Zucker rats fed the HC was markedly lower (P , 0.01)
than in the fa/fa Zucker rats fed the HsF diet or the LC-HsF-HP
diet.
Despite the similar body weight gain in Wistar rats fed the
different diets, the average daily energy intake was markedly
reduced in the LC-HsF-HP fed rats compared with HC fed rats
(P , 0.01). The 24-h-energy intake was also signiﬁcantly
lower for the rats fed the HsF diet compared with those fed the
HC diet (P , 0.05). In the fa/fa Zucker rats, however, average
daily energy intake was signiﬁcantly elevated in the HsF group
(P , 0.01) relative to the HC group. Increasing the percentage
of proteins at the expense of carbohydrates (LC-HsF-HP diet)
induced a signiﬁcant reduction in energy intake (P , 0.01),
with a 24-h energy intake equivalent to that of the fa/fa Zucker
rats fed the HC diet.
FEs were signiﬁcantly elevated in both fa/fa Zucker and
Wistar rats fed the HsF and LC-HsF-HP diets compared with
those fed the HC diet. As opposed to energy intake and body
weight gain being affected differentially by diet composition in
Wistar and fa/fa Zucker rats, the direction of change of FEs by
diet composition appeared comparable in Wistar and fa/fa
Zucker rats.
IVGTTs. Between day 45 and day 50, animals were sub-
jected to an IVGTT (Fig. 2, A–D) to assess their glucose
tolerance and associated insulin responses. The ANOVA with
repeated measures revealed a signiﬁcant time z diet effect on
plasma glucose levels in Wistar rats (P 5 0.0001). Plasma
glucose levels were signiﬁcantly lower in the HC-fed rats at
t 5 20 and t 5 26 min (P , 0.05) after the start of the infusion
compared with those measured in the rats fed the HsF diet, as
well as the LC-HsF-HP diet (P , 0.05 at 20 min only). No
interaction effect was found in fa/fa Zucker rats. With respect
to the AUCs of the glucose responses, however, there was a
signiﬁcant diet effect in both Wistar (P 5 0.030) and fa/fa
Zucker (P 5 0.005) rats, with the lowest AUCs calculated for
the rats fed the HC diet compared with the HsF, and particu-
larly compared with the LC-HsF-HP diets (see Fig. 2 for
details).
In both fa/fa Zucker and Wistar rats, there was a signiﬁcant
time z diet interaction on plasma insulin proﬁles during the
IVGTT (P 5 0.066 and P 5 0.041, respectively). The pattern
of the plasma insulin response of the fa/fa Zucker rats fed the
HC diet was markedly different compared with those observed
in the other two groups. The basal plasma insulin level was
higher (39.9 6 5.1 ng/ml, P , 0.05) in the fa/fa Zucker rats fed
the HC diet than in those fed the HsF or LC-HsF-HP diets
Fig. 1. A: average daily energy intake (kcal)
calculated between day 0 and day 21 (i.e.,
before the surgeries were performed) in fa/fa
Zucker and Wistar rats fed a high-carbohydrate
(HC), high-fat (HsF), or low-carbohydrate,
high-fat, high-protein (LC-HsF-HP) diet. B:
body weight gain (g) calculated over the same
period of time in fa/fa Zucker and Wistar rats
fed a HC, HsF, or LC-HsF-HP diet. C: food
efﬁciencies (mg body wt/kcal) of fa/fa Zucker
and Wistar rats fed a HC, HsF, or LC-HsF-HP
diet. Values are presented as means 6 SE;
*P , 0.05, **P , 0.01.
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 (23.6 6 2.9 and 23.2 6 2.9 ng/ml, respectively). Moreover, the
plasma insulin levels in the fa/fa Zucker rat fed the HC diet
remained higher during the 10 ﬁrst min of the glucose infusion,
and no further glucose-induced increase was observed. How-
ever, after the end of the infusion, plasma insulin decreased.
No signiﬁcant differences were observed among groups in
Wistar or in fa/fa Zucker rats regarding the AUCs of the insulin
responses.
ISTs. The intraperitoneal insulin injection induced an in-
crease of plasma insulin together with a decrease of plasma
glucose as presented in Fig. 3, A–D. In the fa/fa Zucker rats, the
intraperitoneal injection of insulin resulted in similar increases
in plasma insulin levels, which plateaued after t 5 30 min. No
signiﬁcant diet effect was found on plasma glucose levels. In
the Wistar rats, the intraperitoneal injection of insulin led to
increments in the plasma insulin level, and these were associ-
ated with reductions in plasma glucose levels as well. The
decline from baseline in plasma glucose levels was signiﬁ-
cantly less pronounced in the HsF (25.1%) and the LC-HsF-
HP-fed (211.3%) rats compared with HC fed (226.6%) rats
15 min after the intraperitoneal insulin injection (P , 0.05,
HsF and LC-HsF-HP vs. HC). Interestingly, the Wistar rats
could be assigned, in each dietary group, to subcohorts, either
responding with an increase of plasma insulin (IST1) or not
(IST2) to the intraperitoneal insulin injection. Although most
animals in the HC (n 5 7 out of 11) and HsF diet groups (n 5
8 out of 11) reacted with IST1, only 3 out of 11 rats (27%) did
in the LC-HsF-HP group.
Plasma fuels and hormones, and body composition. After
decapitation of the rats, blood was collected to measure fuels
and hormones, and the results of these analyses are shown in
Table 2. In both fa/fa Zucker and Wistar rats, plasma insulin
levels were signiﬁcantly affected by diet composition
(ANOVA, diet effect, P , 0.0001 and P 5 0.045, in the fa/fa
Zucker and Wistar rats, respectively). The fa/fa Zucker rats fed
the HC diet had markedly elevated basal insulin levels (43.3 6
2.9 ng/ml) compared with those fed the HsF or LC-HsF-HP
diets (30.7 6 2.5 and 24.7 6 2.0 ng/ml, respectively). Con-
cerning the Wistar rats, basal insulin was signiﬁcantly reduced
in the LC-HsF-HP group compared with the HsF group (1.7 6
0.1 vs. 2.2 6 0.2 ng/ml, P , 0.05). Within both rat lines, leptin
levels remained unaffected by diet composition. Adiponectin
tended to be elevated in fa/fa Zucker rats fed the HC diet
compared with the LC-HsF-HP and especially the HsF group
(P . 0.05). The ANOVA revealed a signiﬁcant diet effect on
adiponectin and resistin levels in Wistar rats fed the HC diet
compared with those fed the LC-HsF-HP diet, with signiﬁ-
cantly decreased adiponectin and signiﬁcantly increased resis-
tin plasma levels. No such differences were detected between
the HsF and LC-HsF-HP groups. Plasma glucose and FFA
levels remained unaffected by the composition of the diets, in
both the fa/fa Zucker and the Wistar rats. Plasma levels of
triglycerides were signiﬁcantly affected only in the fa/fa
Zucker rats, with elevated levels in the HsF and LC-HsF-HP
groups relative to the HC fed rats. In contrast, plasma ketone
levels were increased only in the Wistar rats fed the HsF or the
LC-HsF-HP diets compared with those fed the HC diet, and
this difference was signiﬁcant for the LC-HsF-HP group only
(196.6 6 11.6 vs. 145.9 6 10.2 mg/ml in the HC group, P ,
0.05). Such an effect was not observed in the fa/fa Zucker rats.
At the end of dietary treatments, the observed effects of diet
on body weight in the fa/fa Zucker rats had disappeared, and
again, no signiﬁcant effects were observed in Wistar rats.
Within each rat line, there was no signiﬁcant effect of the diet
on organ and tissue weight. This was probably due to the
relatively large individual differences in body weight among
Fig. 2. Intravenous glucose tolerance test. A:
plasma glucose (mM) in fa/fa Zucker rats. B:
plasma insulin (ng/ml) in fa/fa Zucker rats. C:
plasma glucose (mM) in Wistar rats. D:
plasma insulin (ng/ml) in Wistar rats. Rats
were fed either an HC, HsF, or LC-HsF-HP
diet. Values with the same letter are signiﬁ-
cantly different, P , 0.05. The dotted lines
indicate when the infusion was performed.
The bars represent the areas under the curve
calculated for each parameter (between 0 and
50 min). Values are presented as means 6
SE; *P , 0.05.
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 animals within each dietary group. When normalized for body
weight, however, the ANOVA revealed a signiﬁcant diet effect
on retroperitoneal fat mass and liver weight in the Wistar rats,
but not in the fa/fa Zucker rats, as shown in Table 3. Post hoc
analysis revealed reduced liver weight in the LC-HsF-HP-fed
Wistar rats compared with the HC fed ones. Retroperitoneal fat
mass was heavier in the HsF and LC-HsF-HP-fed Wistar rats
than in those fed the HC diet.
Correlation analysis. For the Wistar rats and within each
dietary group, the unresponsiveness to the IST seemed to be
paralleled by relatively higher resistin and lower adiponectin
levels; those differences were signiﬁcant only in the LC-HsF-
HP-fed rats (for plasma resistin, IST2: 2.9 6 0.5 vs. IST1:
0.9 6 0.1 ng/ml, P , 0.05; for plasma adiponectin IST2:
1.2 6 0.1 vs. IST1: 1.8 6 0.3 ng/ml, P , 0.05).
DISCUSSION
There is an increasing number of reports suggesting that
low-carbohydrate diets may be beneﬁcial in the treatment of
obesity in humans (4). However, the long-term metabolic
consequences still remain a matter of debate. Adverse health
consequences might be expected to occur with prolonged
ingestion of low-carbohydrate diets, since these usually contain
large amounts of (saturated) fat. The present study focused on
the metabolic consequences of HsF diets with a high or a low
carbohydrate/protein ratio in obese fa/fa Zucker rats and lean
Wistar rats, and these effects were compared with results
obtained in rats fed a HC control diet.
Unlike what has been reported in humans, lean and geneti-
cally obese rats chronically fed a LC-HsF-HP did not have a
Table 2. Plasma concentration of fuels and hormones measured after 60 days of dietary treatment
Diet
Zucker fa/fa Rats
Diet Effect
P value Wistar Rats
Diet effects
P value
HC HsF LC-HsF-HP HC HsF LC-HsF-HP
Glucose, mmol/l 7.760.2 7.760.1 7.660.2 ns 7.760.2 7.560.1 8.160.2 ns
Free fatty acids, mmol/l 0.860.1 0.860.1 0.760.1 ns 0.860.2 1.060.2 0.760.1 ns
Triglycerides, mmol/l 1.160.1a,b 1.360.1a 1.260.1b 0.007 0.860.1 0.960.1 0.660.1 ns
Ketones, mg ml 95.6611.2 96.1618.6 95.768.5 ns 145.9610.2c 171.6611.6 196.6611.6c 0.019
Insulin, ng/ml 43.362.9a,b 30.762.5a 24.762.0b ,0.0001 2.060.1 2.260.2c 1.760.1c 0.045
Leptin, ng/ml 34.667.4 25.368.1 29.863.7 ns 3.960.4 4.260.5 3.860.3 ns
Adiponectin, mg/ml 4.960.3 4.060.2 4.460.4 ns 1.860.1c 1.560.1 1.460.1c 0.034
Resistin, ng/ml 2.060.3 1.660.3 2.160.3 ns 1.460.3c 1.660.1 2.460.4c 0.033
Values are expressed as means 6 SE. Statistical comparisons are for treatment within genotype. Values with the same letter within a row are signiﬁcantly
different (P , 0.05); ns, not signiﬁcant.
Fig. 3. Insulin sensitivity test. A: plasma glu-
cose (mM) in fa/fa Zucker rats. B: plasma
insulin (ng/ml) in fa/fa Zucker rats. C: plasma
glucose (mM) in Wistar rats. D: plasma insu-
lin (ng/ml) in Wistar rats. Rats were fed either
a HC, a HsF, or a LC-HsF-HP diet. Each
arrow indicates the time of the intraperitoneal
injection.
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 lower body weight gain than rats either on a HsF diet with a
high-carbohydrate/protein ratio or on a HC lab chow control
diet. In the obese fa/fa Zucker rats, but not in the Wistar rats,
body weight gain was even ampliﬁed on the HsF, as well as on
the LC-HsF-HP diets compared with what was observed with
the HC diet. These effects, however, were transient and disap-
peared at the end of the dietary treatment, and this effect may
have been paralleled by the similar weights of retroperitoneal
fat pads (i.e., a correlate of body adiposity) in the fa/fa Zucker
rats at the end of the different dietary treatments. Analogous
transient effects of diets with different macronutrient content
on body weight in fa/fa Zucker rats have previously been
reported by Vasselli et al. (34), and these authors suggested
that this was the result of a ceiling effect or “breakpoint”
imposed by maximal storage capacity of adipose tissue in these
animals. In the Wistar rats, however, relative weights of
retroperitoneal fat pads in the HsF and LC-HsF-HP fed animals
were higher compared with those observed in Wistar rats fed
the HC diet, indicating increased body adiposity despite similar
body weights.
Even though body weight was not reduced by the HsF and
LC-HsF-HP diets, there were reductions in energy consump-
tion in the HsF-fed, and particularly in the LC-HsF-HP-fed
Wistar rats (212.4%) compared with the HC-fed ones. An-
orexigenic effects of a diet with a high-fat content may be
attributed to its “ketogenic” character, which would obviously
be even more accentuated when carbohydrates are replaced by
protein in such a diet. This scenario is of course relevant to our
study in which plasma ketone levels of HsF-fed Wistar rats and
particularly of LC-HsF-HP-fed Wistar rats were increased
relative to the level found in HC fed rats. In contrast to the
Wistar rats, plasma ketone levels were not different among diet
groups of obese fa/fa Zucker rats. This is in line with other
studies underscoring congruous inhibited fat oxidation and
reduced ketogenesis in fa/fa Zucker rats (e.g., 31). Another
mechanism that may have contributed to reduced energy in-
take, at least in the LC-HsF-HP group is that the elevated
dietary protein content has speciﬁc satiating effect (for a
review, see Ref. 29), and these effects may persist when the
diet is also high in fat. This “protein” effect of the LC-HsF-HP
diet may not be limited to Wistar rats, as fa/fa Zucker rats also
had reduced consumption of the LC-HsF-HP diet compared
with those fed the HsF diet. An effect of elevated dietary
protein content to cause a reduction of food intake in fa/fa
Zucker rats is in line with reports of Peret et al. (22) and
Vasselli and Maggio (33).
As mentioned above, relative reductions in intake of the
LC-HsF-HP (Wistar and fa/fa Zucker rats) and of the HsF
(Wistar rats only) diets were not associated with a lower body
weight gain. One implication of this phenomenon is that the
consumption of diets with a high fat content (or conversely
with a low carbohydrate content) renders animals more efﬁ-
cient with their ingested calories (5, 10, 32). These results are
in agreement with our previous ﬁndings showing that high-fat
feeding, irrespective of protein/carbohydrate content, increases
food efﬁciency in Wistar rats, as well as in rats rendered obese
by a chronic pharmacological impairment of the central mela-
nocortin system (18). Our current data show that leptin signal-
ing is not required for this effect.
In general, fa/fa Zucker rats were less glucose tolerant and
extremely hyperinsulinemic compared with Wistar rats, which
underscores the nature of the obesity and insulin resistance
model that these leptin receptor-deﬁcient animals represent.
Within both rat lines, glucose tolerances were reduced in rats
fed the HsF and particularly the LC-HsF-HP diet compared
with those fed the HC diet. Regarding the Wistar rats, the
observed glucose intolerances during the IVGTT were associ-
ated with similar, or slightly increased insulin responses, which
is indicative of a reduced whole body insulin-induced glucose
uptake (5, 12, 28, 35). And, indeed, insulin sensitivity—
indexed by the magnitude of insulin-induced hypoglycemia
during the IST—was most attenuated in Wistar rats fed the
LC-HsF-HP diet compared with those fed the HC diet. At ﬁrst
sight, these data may be interpreted to indicate that diet-
induced changes in insulin sensitivity contribute to alteration in
glucose homeostasis in the Wistar rats. Consistent with this
idea would be the observation that plasma levels of adiponectin
and resistin—hormones that respectively increase (9) and
reduce (15, 36) glucose tolerance and insulin sensitivity—were
consistently altered by the LC-HsF-HP diet in the Wistar rats.
Furthermore, analysis of the individual data collected during
the IST revealed that 8 out of 11 of the LC-HsF-HP fed Wistar
rats did not respond at all to the intraperitoneal injection of
insulin, either with a decrease in plasma glucose or with an
elevated plasma insulin level. Closer inspection revealed that
the “insulin-nonresponders” (IST2) had signiﬁcantly in-
creased plasma resistin (1222%) and decreased adiponectin
(233%) levels compared with those that did respond to the
injection (IST1). In addition, the IST2 rats also presented an
increased—though not signiﬁcant (P 5 0.077)—food efﬁ-
ciency (IST2: 0.048 6 0.002 and IST1: 0.042 6 0.001
g/kcal). At this point, we do not know whether the reduced
insulin levels found in plasma were the result of increased
clearance or blunted passage from the abdominal cavity to the
bloodstream. The ﬁrst possibility does not seem very likely, as
no differences in baseline (i.e., endogenous) levels of insulin
Table 3. Body composition after 60 days of dietary treatment
Zucker fa/fa Rats Wistar Rats
Diet HC HsF LC-HsF-HP
Diet effect
P value HC HsF LC-HsF-HP
Diet effect
P value
Liver 3.7760.25 3.1960.13 3.6160.15 ns 3.1160.07a 2.8860.10 2.7260.07a 0.012
Kidneys 0.7360.16 0.5660.02 0.6660.06 ns 2.760.1 2.760.2 2.960.1 ns
Retroperitoneal fat 4.3260.20 4.3660.32 4.2860.17 ns 1.2360.09a,b 1.6460.10a 1.6460.11b 0.016
Gastrointestinal tract (full) 9.8460.35 9.5360.47 9.0760.36 ns 7.5160.71 7.7260.88 6.6560.53 ns
Eviscerated carcass 78.260.9 76.061.0 76.960.3 ns 79.360.7 79.460.4 80.160.2 ns
Values are presented as percentage of body weight and expressed as means 6 SE. Statistical comparisons are for treatment within genotype. Values with the
same letter within a row are signiﬁcantly different (P , 0.05).
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 were observed between IST1 and IST2 rats. To consider the
second hypothesis, it might be imagined that exogenous insulin
uptake by the abdominal capillary beds is highly variable
among animals fed a ketogenic diet, and that “adipocytokines,”
such as resistin play a role in this mechanism. Although we
have no direct evidence for such an effect, this idea may be
corroborated by the recent ﬁndings of Mu et al. (19) showing
that resistin has potent stimulatory effects on capillary angio-
genesis, which potentially could impair insulin transport across
capillary walls. Such an effect on capillary beds may be caused
by resistin originating from adipose tissue or by resistin se-
creted from macrophages (21). We are currently investigating
these potential mechanisms, as they could be relevant for
diabetic patients on insulin therapy.
As opposed to the Wistar rats, no large differences in plasma
insulin levels after insulin injection were observed between
fa/fa Zucker rats in the different dietary groups, nor were there
large differences in plasma levels of resistin and adiponectin
within and between dietary groups. An issue that deserves
attention in this respect is the fact that, while different dietary
groups of fa/fa Zucker had comparable insulin levels at base-
line before the IST, fa/fa Zucker rats fed the HC diet were
markedly hyperinsulinemic at baseline before the IVGTT rel-
ative to the other dietary groups. In the case of the IVGTT, this
elevated basal plasma insulin level was followed by a highly
disturbed—and in some animals even absent—insulin response
during the IVGTT. These effects could be the result of post-
ingestive consequences of the HC diet in the fa/fa Zucker rats,
since the period of food deprivation prior to the IVGTT (8–9
h during the light phase) was shorter than prior to the IST
(overnight and light phase). Although this was not detrimental
for glucose homeostasis in fa/fa Zucker rats fed the HC diet in
the present study, it may be anticipated that obese subjects of
a species with a lower maximal or more “labile” B-cell capac-
ity than fa/fa Zucker rats [i.e., such as humans (25)] could be
at risk of developing B-cell failure to compensate the insulin
resistance frequently associated with obesity. In that respect,
consuming a diet with a relatively low carbohydrate content
might be less detrimental. Finally, future experiments will be
necessary to indicate the effects of the quality of added dietary
protein and fatty acids, which have been used in the formula-
tion of the low-carbohydrate diet in the present study. This is
necessary since protein and fatty acid sources used to prepare
the low-carbohydrate diet (i.e., casein and mostly saturated fat,
respectively, in the present experiment) differed from those
that were already supplied in the HC diet. It is possible that
these different sources of protein and fatty acids in the HsF and
LC-HsF-HP diet also have speciﬁc effects on energy balance
and glucose homeostasis (3, 30).
In conclusion, our work shows that consuming a LC-
HsF-HP diet causes impaired glucose tolerance in lean Wistar
as well as obese fa/fa Zucker rats, an effect that is probably due
to the high level of saturated dietary fat. Although this indi-
cates similar adverse consequences of such a diet on blood
glucose homeostasis in lean and obese rats, there appear to be
principal differences in the underlying hormonal regulatory
mechanisms, which could have beneﬁts for B-cell functioning
and insulin action in the obese, but not in the lean state.
Because no reductions in body weight and retroperitoneal fat
pad weights were observed in lean and obese rats when fed the
LC-HsF-HP diet (despite reductions in energy intake, which
appeared to be compensated by increases in food efﬁciency),
these ﬁndings may be of particular importance for individuals
for whom the diet is not very beneﬁcial in their attempt to lose
weight. Future studies should perhaps be focused on body
weight effects and health consequences of low-carbohydrate
diets with a higher protein content at the expense of dietary fat.
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